Mug110 refers to a meiosis-upregulated gene in Schizosaccharomyces pombe (fission yeast) encoding an RNA-binding protein of unknown function. It interacts with Crp79, another RNA-binding protein, but no antibody targeting Mug110 has been reported .
4T1 Orthotopic Breast Cancer Model:
CT-26 Lung Metastasis Model:
EpCAM expression in normal tissues (e.g., pancreas, lung) did not result in off-target toxicity during prolonged dosing .
MT110, the human EpCAM/CD3 BiTE counterpart, entered a Phase 1 trial in 2008 for lung/gastrointestinal cancers :
Objective: Assess safety, pharmacokinetics, and tumor response.
Rationale: EpCAM is expressed on cancer stem cells, implicated in metastasis .
| Antibody | Target | Development Stage (2008) |
|---|---|---|
| MT103 | CD19/CD3 | Phase 2 (hematologic cancers) |
| MT110 | EpCAM/CD3 | Phase 1 (solid tumors) |
Cytotoxicity Assay: Propidium iodide uptake measured via flow cytometry (FACSCalibur) .
T-Cell Activation: PBMC/splenocyte co-culture with EpCAM⁺ CHO cells .
EpCAM expression patterns in murine and human tissues showed 85% homology, validating translational relevance .
Mug110 Gene Product: No studies have characterized an antibody against the fission yeast Mug110 protein.
MuS110 Clinical Translation: Despite promising murine data, MT110’s clinical outcomes remain undisclosed in public domains post-2008.
KEGG: spo:SPBC2G2.10c
STRING: 4896.SPBC2G2.10c.1
Mug110 (also known as meiotically upregulated gene 110) is a protein found in Schizosaccharomyces pombe (fission yeast) that appears to be involved in DNA repair mechanisms. Based on comparative studies with other DNA repair proteins, it may play a role in maintaining genomic integrity in response to DNA damage, particularly in pathways similar to those involving Fan1 and other DNA repair components that resolve DNA interstrand cross-links . Understanding mug110 function contributes to our broader knowledge of DNA damage response systems in eukaryotes.
Currently, rabbit polyclonal antibodies against mug110 are commercially available for research applications . These antibodies are typically raised against specific epitopes of the mug110 protein and can be used in various molecular and cellular biology techniques. Unlike monoclonal antibodies that recognize a single epitope, polyclonal antibodies bind to multiple epitopes on the target protein, which can provide advantages in certain experimental contexts.
Small volumes of anti-mug110 antibody vials may occasionally become entrapped in the seal of the product vial during shipment and storage . For optimal performance, antibodies should generally be stored according to manufacturer recommendations, typically at -20°C for long-term storage and 4°C for short-term use. Repeated freeze-thaw cycles should be avoided by preparing small aliquots. When handling, maintain sterile conditions and use appropriate laboratory techniques to prevent contamination or degradation.
Mug110 antibodies can be utilized in several key molecular biology techniques:
Western Blotting: For detecting and quantifying mug110 protein expression levels in cell or tissue lysates, similar to techniques used for Fan1 protein analysis .
Immunoprecipitation: To isolate mug110 and its interacting partners, following protocols similar to those described for Fan1-13myc immunoprecipitation studies .
Immunofluorescence: For visualizing mug110 subcellular localization and potential co-localization with other proteins.
Chromatin Immunoprecipitation (ChIP): To identify DNA regions where mug110 might bind, particularly relevant for DNA repair proteins.
Optimizing Western blot protocols for mug110 detection requires systematic testing of several parameters:
For co-immunoprecipitation studies to identify mug110 interacting partners:
Prepare cell lysates using appropriate lysis buffers that maintain protein-protein interactions
Pre-clear lysates with Protein A/G beads to reduce non-specific binding
Incubate cleared lysates with anti-mug110 antibody (typically 2-5 μg per 1 mg of total protein)
Add Protein A/G beads to capture antibody-protein complexes
Wash thoroughly to remove non-specific interactions
Elute bound proteins and analyze by Western blotting or mass spectrometry
This approach is similar to the co-immunoprecipitation methodology described for Fan1-13myc in S. pombe studies .
Validating antibody specificity is critical for reliable research results. Consider these approaches:
Genetic Validation: Test antibody in wild-type versus mug110-deleted strains, similar to validation approaches used for Fan1 deletion studies
Peptide Competition Assay: Pre-incubate antibody with excess immunizing peptide before application
Signal Correlation: Compare protein expression pattern with mRNA expression data
Multiple Antibody Validation: If available, compare results using different antibodies against different epitopes of mug110
Mass Spectrometry: Confirm identity of immunoprecipitated proteins
Essential controls for mug110 antibody experiments include:
Positive Controls: Samples known to express mug110 protein
Negative Controls: Samples with mug110 deletion or knockdown
Isotype Controls: For immunoprecipitation and immunofluorescence, use species-matched non-specific IgG
Loading Controls: For Western blotting, include housekeeping proteins
Epitope Tags: When possible, compare results with epitope-tagged mug110 detected with tag-specific antibodies, similar to verification methods used with Fan1-13myc
When encountering issues with antibody performance:
| Problem | Troubleshooting Approach |
|---|---|
| Weak Signal | Increase antibody concentration, extend incubation time, use more sensitive detection methods |
| High Background | Optimize blocking (longer time, different blocking agent), increase washing stringency, decrease antibody concentration |
| Multiple Bands | Verify sample preparation (prevent degradation), test antibody on knockout controls, optimize running conditions |
| No Signal | Confirm protein expression, check extraction method compatibility, verify secondary antibody reactivity |
| Variable Results | Standardize protocols, prepare fresh working solutions, use consistent protein amounts |
For investigating mug110's role in DNA damage response:
Damage-Induced Localization: Track mug110 localization before and after treatment with DNA damaging agents (UV, cisplatin, mitomycin C) using immunofluorescence
Interaction Dynamics: Examine changes in mug110 interactions following DNA damage using co-immunoprecipitation
Chromatin Association: Perform ChIP to determine if mug110 associates with damaged DNA regions
Pathway Analysis: Use antibodies in combination with genetic studies of other DNA repair proteins, similar to epistatic analyses performed with Fan1 and Pso2
Quantitative Assessment: Measure changes in mug110 protein levels in response to different types of DNA damage
When integrating mug110 antibodies into high-throughput screens:
Assay Miniaturization: Optimize antibody concentration for reduced volumes while maintaining signal-to-noise ratio
Automation Compatibility: Ensure antibody performance is consistent under automated handling conditions
Batch Variability: Characterize lot-to-lot variation and prepare sufficient stocks for entire screening campaign
Multiplexing Potential: Determine compatibility with other antibodies for multi-parameter analysis
Data Analysis: Develop standardized quantification methods that account for technical variations
This approach can be modeled after high-throughput genetic screens described for Fan1 and other DNA repair components .
To investigate post-translational modifications (PTMs) of mug110:
Modification-Specific Antibodies: When available, use antibodies that specifically recognize phosphorylated, ubiquitinated, or SUMOylated forms of mug110
Combined Approaches: Use anti-mug110 antibodies for immunoprecipitation followed by PTM-specific antibodies for detection
Phos-tag Gels: Combine mug110 antibodies with Phos-tag SDS-PAGE to detect phosphorylated forms
Mass Spectrometry: Use antibodies to purify mug110 followed by MS analysis of modifications
Modification Inhibitors: Combine antibody detection with inhibitors of specific modification pathways (kinases, SUMO ligases) to study regulation
This is particularly relevant given the potential connections between SUMOylation pathways and DNA repair mechanisms, as suggested by non-epistatic relationships between Fan1 and Pli1, a component of the SUMOylation pathway .
When considering cross-species applications:
Sequence Homology: Analyze epitope conservation across species to predict cross-reactivity
Validation Testing: Empirically test antibody performance in each species of interest
Control Samples: Include positive controls from S. pombe alongside experimental samples
Optimization Requirements: Modify protocols (extraction methods, antibody concentration) for each species
Alternative Approaches: Consider epitope tagging of homologous proteins in species where antibody cross-reactivity is poor
Methodological similarities and differences include: